Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 671.40
Bid: 670.40
Ask: 670.80
Change: -7.80 (-1.15%)
Spread: 0.40 (0.06%)
Open: 679.80
High: 683.80
Low: 670.40
Prev. Close: 679.20
STAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Suppl.Prospcts

21 Sep 2018 16:37

RNS Number : 6067B
Standard Chartered PLC
21 September 2018
 

Standard Chartered PLC andStandard Chartered Bank

21 September 2018

NOT FOR DISTRIBUTION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES

Publication of Supplementary Prospectus

The following supplementary prospectus has been approved by the UK Listing Authority and is available for viewing:

Supplementary Prospectus dated 21 September 2018 (the "Supplementary Prospectus") supplementing the Base Prospectus dated 19 June 2018 (the "Base Prospectus") relating to a US$77,500,000,000 Debt Issuance Programme with Standard Chartered PLC and Standard Chartered Bank as issuers (the Base Prospectus as supplemented from time to time, the "Prospectus").

To view the full document, together with the documents incorporated by reference, please paste the following URLs into the address bar of the browser.

http://www.rns-pdf.londonstockexchange.com/rns/6067B_1-2018-9-21.pdf

A copy of the Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM 

For further information, please contact: 

Daniel BanksDebt Investor Relations1 Basinghall AvenueLondonEC2V 5DD020 7885 6329

Jon TraceyGlobal Head, Communications1 Basinghall AvenueLondonEC2V 5DD020 7885 7613

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Supplementary Prospectus and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Supplementary Prospectus or the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

The Notes offered by the Prospectus have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), or any relevant securities laws of any state of the United States and are subject to U.S. tax law requirements. Subject to certain exceptions, the Notes may not be offered, sold or delivered in the United States, as defined in Regulation S under the Securities Act. The Prospectus may not be accessed from, or transmitted in or into, the United States.

Your right to access this service is conditional upon complying with the above requirement.

Standard Chartered PLC LEI: U4LOSYZ7YG4W3S5F2G91

Standard Chartered Bank LEI: RILFO74KP1CM8P6PCT96

 

END.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PSPPGUCGBUPRGAG
Date   Source Headline
28th Mar 20246:00 pmRNSTransaction in Own Shares
27th Mar 20246:22 pmRNSNotice to ADR Holders of 6.409% Preference Shares
27th Mar 20245:39 pmRNSTransaction in Own Shares
26th Mar 20245:35 pmRNSTransaction in Own Shares
26th Mar 20244:36 pmRNSDirector/PDMR Shareholding
25th Mar 20245:43 pmRNSTransaction in Own Shares
22nd Mar 20245:35 pmRNSTransaction in Own Shares
21st Mar 20245:55 pmRNSTransaction in Own Shares
20th Mar 20245:30 pmRNSTransaction in Own Shares
20th Mar 20243:08 pmRNSDirector/PDMR Shareholding
19th Mar 20246:05 pmRNSTransaction in Own Shares
19th Mar 20245:45 pmRNSPublication of Final Terms
18th Mar 20245:51 pmRNSTransaction in Own Shares
15th Mar 20245:53 pmRNSTransaction in Own Shares
15th Mar 20244:45 pmRNSHolding(s) in Company
15th Mar 20244:30 pmRNSDirector/PDMR Shareholding
15th Mar 20243:35 pmRNSDirector/PDMR Shareholding
15th Mar 202410:30 amRNSHolding(s) in Company
14th Mar 20246:05 pmRNSTransaction in Own Shares
14th Mar 20242:03 pmRNSTotal Voting Rights
14th Mar 202411:05 amRNSDirector/PDMR Shareholding
13th Mar 20246:02 pmRNSTransaction in Own Shares
13th Mar 20246:00 pmRNSPublication of Supplementary Prospectus
13th Mar 202411:26 amRNSOverseas Regulatory Announcement – Grant of awards
13th Mar 202410:45 amRNSDirector/PDMR Shareholding
12th Mar 20246:00 pmRNSTransaction in Own Shares
12th Mar 20242:54 pmRNSDirector/PDMR Shareholding
12th Mar 202410:57 amRNSOverseas Regulatory Announcement - Grant of awards
12th Mar 202410:00 amRNSStandard Chartered: Management Team Change
11th Mar 20246:23 pmRNSTransaction in Own Shares
8th Mar 20245:59 pmRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20246:02 pmRNSTransaction in Own Shares
6th Mar 202411:33 amRNSNotice of Redemption
5th Mar 20246:15 pmRNSTransaction in Own Shares
4th Mar 20246:04 pmRNSTransaction in Own Shares
1st Mar 20245:50 pmRNSTransaction in Own Shares
1st Mar 202412:00 pmRNSTotal Voting Rights
29th Feb 20246:15 pmRNSTransaction in Own Shares
29th Feb 20244:21 pmRNSPublication of Final Terms
29th Feb 20247:00 amRNSIssuance of U.S.$1bn Additional Tier 1 Securities
29th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20246:09 pmRNSTransaction in Own Shares
26th Feb 202410:03 amRNSShare Buy-Back
23rd Feb 20242:39 pmRNSFull Year 2023 Pillar 3 Disclosures
23rd Feb 202412:13 pmRNSPublication of Supplementary Prospectus
23rd Feb 20247:00 amRNSAnnual Report 2023
23rd Feb 20247:00 amRNSAdditional Financial Information - Part 2
23rd Feb 20247:00 amRNSAdditional Financial Information - Part 1
23rd Feb 20247:00 amRNSSCPLC Final Results 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.